FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024221433> ?p ?o ?g. }

• W2024221433 endingPage "531" @default.
• W2024221433 startingPage "522" @default.
• W2024221433 abstract "Cannabinoid CB1 receptor (CB1R) signaling has been suggested to play an important role in the regulation of memory and cognition. In the present study, our aim was to investigate whether the CB1R antagonist SLV330 (doses ranging from 0.3 to 10 mg/kg, given orally, p.o.) could ameliorate impairments in distinct aspects of cognition using different disruption models in both mice and rats. Effects of SLV330 were tested on working memory deficits in the T-maze Continuous Alternation Task (T-CAT) in mice; episodic memory deficits in the Object Recognition Task (ORT) and Social Recognition Task (SRT) in rats. The acetylcholinesterase inhibitor (AChEI) donepezil (Aricept®, approved for symptomatic treatment of Alzheimer’s disease) and nicotine were used as reference compounds. SLV330 markedly improved aging and scopolamine-induced memory deficits in the T-CAT in mice with a lowest effective dose (LED) of 1 mg/kg p.o., while reversing the cognitive dysfunction induced by the N-methyl-d-aspartate (NMDA) antagonist dizocilpine (MK-801) only at the middle dose of 3 mg/kg. In the ORT, we have found that combined administration of subthreshold doses of SLV330 (1 mg/kg, p.o.) and the AChEI donepezil (0.1 mg/kg, p.o.), that had no discernable effects on performance when given alone, enhanced memory performance in Wistar rats with deficits induced by the muscarinic antagonist scopolamine, suggestive of additive synergistic effects of SLV330 and donepezil on cognitive impairment. Finally, SLV330 was found to have cognition enhancing properties in a time delay paradigm in the SRT at a LED dose of 3 mg/kg (p.o.). In conclusion, the CB1R antagonist SLV330 was found to clearly improve memory in several preclinical models for cognitive impairment." @default.
• W2024221433 created "2016-06-24" @default.
• W2024221433 creator A5005879788 @default.
• W2024221433 creator A5008166228 @default.
• W2024221433 creator A5017505906 @default.
• W2024221433 creator A5025743860 @default.
• W2024221433 creator A5038452775 @default.
• W2024221433 creator A5043621248 @default.
• W2024221433 creator A5054657937 @default.
• W2024221433 creator A5055584955 @default.
• W2024221433 creator A5063947698 @default.
• W2024221433 creator A5073179305 @default.
• W2024221433 creator A5085773260 @default.
• W2024221433 date "2010-05-01" @default.
• W2024221433 modified "2023-10-16" @default.
• W2024221433 title "SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents" @default.
• W2024221433 cites W1836729582 @default.
• W2024221433 cites W1967480174 @default.
• W2024221433 cites W1967716137 @default.
• W2024221433 cites W1972019809 @default.
• W2024221433 cites W1972911528 @default.
• W2024221433 cites W1979347858 @default.
• W2024221433 cites W1980612924 @default.
• W2024221433 cites W1982070093 @default.
• W2024221433 cites W1982245441 @default.
• W2024221433 cites W1985637593 @default.
• W2024221433 cites W1985916296 @default.
• W2024221433 cites W1989558275 @default.
• W2024221433 cites W1993681287 @default.
• W2024221433 cites W2018532397 @default.
• W2024221433 cites W2023354455 @default.
• W2024221433 cites W202555250 @default.
• W2024221433 cites W2027085365 @default.
• W2024221433 cites W2029181309 @default.
• W2024221433 cites W2031117153 @default.
• W2024221433 cites W2034266460 @default.
• W2024221433 cites W2037811574 @default.
• W2024221433 cites W2038127101 @default.
• W2024221433 cites W2039075249 @default.
• W2024221433 cites W2047297178 @default.
• W2024221433 cites W2055103087 @default.
• W2024221433 cites W2061609570 @default.
• W2024221433 cites W2064128689 @default.
• W2024221433 cites W2070676372 @default.
• W2024221433 cites W2070834982 @default.
• W2024221433 cites W2072441360 @default.
• W2024221433 cites W2075647580 @default.
• W2024221433 cites W2089711120 @default.
• W2024221433 cites W2107585091 @default.
• W2024221433 cites W2108747591 @default.
• W2024221433 cites W2116687278 @default.
• W2024221433 cites W2116854184 @default.
• W2024221433 cites W2127372827 @default.
• W2024221433 cites W2127696179 @default.
• W2024221433 cites W2127948169 @default.
• W2024221433 cites W2143302321 @default.
• W2024221433 cites W2146896966 @default.
• W2024221433 cites W2151339489 @default.
• W2024221433 cites W2160161356 @default.
• W2024221433 cites W2952529437 @default.
• W2024221433 doi "https://doi.org/10.1016/j.nlm.2010.01.010" @default.
• W2024221433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20132903" @default.
• W2024221433 hasPublicationYear "2010" @default.
• W2024221433 type Work @default.
• W2024221433 sameAs 2024221433 @default.
• W2024221433 citedByCount "43" @default.
• W2024221433 countsByYear W20242214332012 @default.
• W2024221433 countsByYear W20242214332013 @default.
• W2024221433 countsByYear W20242214332014 @default.
• W2024221433 countsByYear W20242214332015 @default.
• W2024221433 countsByYear W20242214332016 @default.
• W2024221433 countsByYear W20242214332017 @default.
• W2024221433 countsByYear W20242214332018 @default.
• W2024221433 countsByYear W20242214332019 @default.
• W2024221433 countsByYear W20242214332020 @default.
• W2024221433 countsByYear W20242214332021 @default.
• W2024221433 countsByYear W20242214332022 @default.
• W2024221433 countsByYear W20242214332023 @default.
• W2024221433 crossrefType "journal-article" @default.
• W2024221433 hasAuthorship W2024221433A5005879788 @default.
• W2024221433 hasAuthorship W2024221433A5008166228 @default.
• W2024221433 hasAuthorship W2024221433A5017505906 @default.
• W2024221433 hasAuthorship W2024221433A5025743860 @default.
• W2024221433 hasAuthorship W2024221433A5038452775 @default.
• W2024221433 hasAuthorship W2024221433A5043621248 @default.
• W2024221433 hasAuthorship W2024221433A5054657937 @default.
• W2024221433 hasAuthorship W2024221433A5055584955 @default.
• W2024221433 hasAuthorship W2024221433A5063947698 @default.
• W2024221433 hasAuthorship W2024221433A5073179305 @default.
• W2024221433 hasAuthorship W2024221433A5085773260 @default.
• W2024221433 hasConcept C126322002 @default.
• W2024221433 hasConcept C148001335 @default.
• W2024221433 hasConcept C15744967 @default.
• W2024221433 hasConcept C169760540 @default.
• W2024221433 hasConcept C169900460 @default.
• W2024221433 hasConcept C170493617 @default.
• W2024221433 hasConcept C181199279 @default.
• W2024221433 hasConcept C185592680 @default.

• next